))
Alzheimer's Speaks Radio gives voice to all, sharing resources, tools, and products. Through collaboration & education we are changing dementia care.
…
continue reading
MCI is an independent, global association, communications and event management company. Our combined expertise enables us to offer strategy, creativity and execution in the field of association management (AMC), Congress and Exhibition (PCO), live communication, meetings, events and incentives and performance improvement programmes. Learn more at http://www.GrowGlobally.com.
…
continue reading
Abdulkareem Chaudhry Ms.Lima Mci English podcast assignment.
…
continue reading
Rev Dr Heather Morris, General Secretary of the Methodist Church in Ireland hosts the 'Living Wholeheartedly' podcast. Subscribe now and join Heather along with special guests as they share stories and answer questions on life, ministry and unpack together what it means to be in relationship with Jesus, for whom the phrase ‘living wholeheartedly as followers of Jesus for the transformation of the world’ is not just an aspiration or a hope – but reality. WATCH on YouTube: https://bit.ly/MCI-Y ...
…
continue reading
Join Anne Fraser as she sheds light on one of the most complex and challenging diseases of our time. Anne explores all facets of Alzheimer's and dementia, providing insights into living with loved ones who suffer from the disease, as well as prevention, treatment, and reversing cognitive decline. Through interviews with leading medical experts, caregivers, and people living with Alzheimer's and dementia, Anne offers practical advice and support to help listeners navigate this difficult journ ...
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
Naturopathic Doctor, Acupuncturist, Chinese herbal medicine, areas of specialty Environmental medicine, nutrition, and nutrigenomics. Clinical practice 20 years.
…
continue reading
Certified Professional Career Coach, personal branding professional and reinvention expert Dr. Garrison Leykam helps listeners live audaciously."You've had such a varied and impressive career. It's awesome to read about your adventures and reinventions and how you're now helping others do the same," branding expert Dorie Clark, contributor to the Harvard Business Review, Entrepreneur and Forbes and author of Entrepreneurial You, Reinventing You, and Stand Out (#1 Leadership Book by Inc. and ...
…
continue reading
Updates on new data and best practices in patient care across a wide variety of psychiatric and neurological illnesses from Clinical Care Options. Gain a deeper understanding and practical clinical insights on topics ranging from bipolar depression to Parkinson’s disease psychosis. Select episodes available for CME/CE credit.
…
continue reading
Welcome to Investment Moments with Momentum Investments, where we talk to investment professionals and financial experts about investments and savings. We unpack all things investments to provide you with better insights for the important discussions with your clients to help them achieve their goals.
…
continue reading
“Digital Alchemists” speaks to software engineering and business capabilities, as well as the related ”mindset shift” especially needed for large entities moving from waterfall to Agile for digital. Episodes are based on enterprise constraints and organizational complexities that are related to this global transformational journey. We will be spotlighting interviews with specialists in business, software engineering, cloud, psychological change, value-based delivery, and many other topics th ...
…
continue reading
Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disea…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/precision-imaging-mris-critical-role-in-early-mci-ad-diagnosis/26343/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Har…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/future-frontiers-the-future-landscape-of-alzheimers-therapeutics/26348/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John H…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/dementia-on-a-spectrum-preclinical-stages-of-mci-in-ad/26339/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discu…
…
continue reading
Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzhei…
…
continue reading
Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disea…
…
continue reading
Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzhei…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/breaking-ground-the-latest-data-on-ad-disease-modifying-therapies/26345/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John …
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/comparative-efficacy-subq-vs-intravenous-dmts-in-alzheimers-disease/26347/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and Joh…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/beyond-guesswork-validated-methods-for-mci-assessment-in-alzheimers-diagnosis/26342/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabba…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/inequity-and-illness-understanding-mci-disease-course-and-severity-for-racial-minorities/26341/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. M…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/therapeutic-insights-navigating-the-use-and-challenges-of-disease-modifying-therapies/26346/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marw…
…
continue reading
Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disea…
…
continue reading
Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzhei…
…
continue reading
Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzhei…
…
continue reading
Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disea…
…
continue reading
Host: Professor Sir John Hardy This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzheimer’s disea…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/markers-of-memory-pathological-biomarkers-of-clinical-mci-due-to-ad/26344/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and Joh…
…
continue reading
Host: Marwan Noel Sabbagh, MD, FAAN, CCRI This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss best practices for recognizing early symptoms, diagnosis, and treatment of mild cognitive impairment and early Alzhei…
…
continue reading
CME credits: 1.00 Valid until: 25-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/the-subtle-onset-understanding-early-mci-ad-symptoms/26340/ This series of micro-episodes will provide important information on slowing progression in mild cognitive impairment and early Alzheimer’s disease. Drs. Marwan Sabbagh and John Hardy discuss…
…
continue reading
Is 38 too young to get Alzheimer's? In this episode of "Bringing Hope to Alzheimer's," Anne Fraser discusses the increasing cases of early-onset Alzheimer's and dementia, with diagnoses occurring as early as the 30s and 40s. Learn about the subtle signs and symptoms that might indicate early stages of Alzheimer's, how to recognize them in yourself …
…
continue reading
1
Chairperson Perspective: Practice-Changing Strategies in Community Care Settings for Patients with CLL/SLL and MCL
CME credits: 0.50 Valid until: 23-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/chairperson-perspective-practice-changing-strategies-in-community-care-settings-for-patients-with-cllsll-and-mcl/18098/ Although covalent Bruton's tyrosine kinase (BTK) inhibitors have proven to be effective in treating chronic lymphocytic leukemia (…
…
continue reading
1
Chairperson Perspective: Practice-Changing Strategies in Community Care Settings for Patients with CLL/SLL and MCL
Host: Matthew S. Davids, MD, MMSc Although covalent Bruton's tyrosine kinase (BTK) inhibitors have proven to be effective in treating chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) or mantle cell lymphoma (MCL), patients still experience poor outcomes after treatment failure or intolerance, necessitating new therapeutic options…
…
continue reading
1
OPEN MIC on Alzheimer's Speaks - Dementia Friendly Churches, Resources, Training, & Insight
1:08:44
1:08:44
Play later
Play later
Lists
Like
Liked
1:08:44
OPEN MIC on Alzheimer's Speaks - Dementia Friendly Churches, Resources, Training, & Insight 7/23/24 Today our host Lori La Bey talks with Pastor Jeanette Bass Jordan founder of Dementia Dignified Academy and Lance A. Slatton known as the Senior Care Influencer. I think you will find our conversation interesting as we explore services, products, car…
…
continue reading
1
The 3 Biggest Obstacles to Losing Weight on Low Carb Keto Diet
45:57
45:57
Play later
Play later
Lists
Like
Liked
45:57
This is the primary distinction between having a brain driven by the need for more dopamine or one that is functioning happily on serotonin. These two very different neurotransmitters predispose your brain to developing specific behavioral styles. One leads to progressive brain damage driven by the always immediate need for more...Dopamine...in oth…
…
continue reading
1
Featured Artist Mark Timmons on Dementia and the Arts
1:42:36
1:42:36
Play later
Play later
Lists
Like
Liked
1:42:36
SPECIAL PROGRAM ALERT - DEMENTIA AND THE ARTS on Alzheimer's Speaks Artist, Mark Timmons joins Dementia and the Arts host Lori La Bey and Mary Crescenzo. On today's show, Mark shares a sampling of his photography as well as some of his prose. In fact, in some pieces, he combines them! Mark shares his techniques, what sparks his interests and why, a…
…
continue reading
1
Case Discussion: What JAK Inhibitor Should I Use in a Transfusion-Dependent Patient With MF With Platelets > 50 × 109/L?
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-discussion-what-jak-inhibitor-should-i-use-in-a-transfusion-dependent-patient-with-mf-with-platelets-50-109l/26512/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhi…
…
continue reading
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/how-and-when-to-manage-ruxolitinib-failure/26505/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly imp…
…
continue reading
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-myelofibrosis-associated-thrombocytopenia/26510/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significa…
…
continue reading
1
How to Use Prognostic Risk Scoring and Symptom Burden Assessment to Tailor Myelofibrosis Treatment
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/how-to-use-prognostic-risk-scoring-and-symptom-burden-assessment-to-tailor-myelofibrosis-treatment/26504/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particu…
…
continue reading
1
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer
CME credits: 0.50 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/chairperson-perspective-precision-payloads-exploring-adc-directed-therapies-in-her2-mutant-and-overexpressing-lung-cancer/16609/ Alterations in ERBB2, the gene encoding HER2, have been recognized as drivers in the development of NSCLC. Therefore, HER…
…
continue reading
1
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer
Host: Joshua E. Reuss, MD Alterations in ERBB2, the gene encoding HER2, have been recognized as drivers in the development of NSCLC. Therefore, HER2 is an actionable biomarker that has emerged in NSCLC diagnosis and treatment. HER2 mutations activate the HER2 signaling pathway, which facilitates oncogenic transformation and increases tumor prolifer…
…
continue reading
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/improving-transfusion-independence-with-jak-inhibitor-therapy/26509/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, ca…
…
continue reading
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-treatment-related-toxicities-with-jak-inhibitor-therapy-in-myelofibrosis/26511/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopen…
…
continue reading
1
How to Use Prognostic Risk Scoring and Symptom Burden Assessment to Tailor Myelofibrosis Treatment
Host: Gabriela Hobbs, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic re…
…
continue reading
Host: Gabriela Hobbs, MD Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly improve patient outcomes. Stay informed on managing ruxolitinib intolerance and recognizing a failure to optimize therapeutic re…
…
continue reading
CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/treatment-options-for-ruxolitinib-intolerance-or-resistance-in-myelofibrosis/26506/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic my…
…
continue reading
